Find Fasoracetam manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 110958-19-5, Fasoracetam [inn], N-(5-oxo-d-prolyl)piperidine, Ns 105 (pharmaceutical), (5r)-5-(piperidine-1-carbonyl)pyrrolidin-2-one, Ns-105
Molecular Formula
C10H16N2O2
Molecular Weight
196.25  g/mol
InChI Key
GOWRRBABHQUJMX-MRVPVSSYSA-N
FDA UNII
42O8UF5CJB

Fasoracetam
Fasoracetam is under investigation in clinical trial NCT03609619 (PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without Mglur Mutations).
1 2D Structure

Fasoracetam

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one
2.1.2 InChI
InChI=1S/C10H16N2O2/c13-9-5-4-8(11-9)10(14)12-6-2-1-3-7-12/h8H,1-7H2,(H,11,13)/t8-/m1/s1
2.1.3 InChI Key
GOWRRBABHQUJMX-MRVPVSSYSA-N
2.1.4 Canonical SMILES
C1CCN(CC1)C(=O)C2CCC(=O)N2
2.1.5 Isomeric SMILES
C1CCN(CC1)C(=O)[C@H]2CCC(=O)N2
2.2 Other Identifiers
2.2.1 UNII
42O8UF5CJB
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-oxo-d-prolinepiperidinamide Monohydrate

2. Ns 105

3. Ns-105

2.3.2 Depositor-Supplied Synonyms

1. 110958-19-5

2. Fasoracetam [inn]

3. N-(5-oxo-d-prolyl)piperidine

4. Ns 105 (pharmaceutical)

5. (5r)-5-(piperidine-1-carbonyl)pyrrolidin-2-one

6. Ns-105

7. (r)-5-(piperidine-1-carbonyl)pyrrolidin-2-one

8. (r)-1-((5-oxo-2-pyrrolidinyl)carbonyl)piperidine

9. Lam-105

10. Nfc1 Anhydrous

11. Nfc-1 Anhydrous

12. Lam105 Anhydrous

13. Lam-105 Anhydrous

14. 42o8uf5cjb

15. Ncgc00182992-01

16. Aevi001

17. Aevi-001

18. Chebi:31592

19. Ns105

20. (+)-1-(((r)-5-oxo-2-pyrrolidinyl)carbonyl)piperidine

21. (5r)-5-(1-piperidinylcarbonyl)-2-pyrrolidinone

22. (r)-1-[(5-oxo-2-pyrrolidinyl)carbonyl]piperidine

23. 2-pyrrolidinone, 5-(1-piperidinylcarbonyl)-, (5r)-

24. Unii-42o8uf5cjb

25. Piperidine, 1-((5-oxo-2-pyrrolidinyl)carbonyl)-, (r)-

26. Dsstox_cid_28781

27. Dsstox_rid_83050

28. Dsstox_gsid_48855

29. Schembl194770

30. Chembl2106179

31. Dtxsid9048855

32. Ex-a736

33. Bcp16788

34. Zinc3779713

35. Tox21_113340

36. Mfcd00875708

37. Ns 105

38. Akos006280726

39. 4-methyl-6-trifluoromethylnicotinicacid

40. Ac-31949

41. Bs-49484

42. Fasoracetam ;aka Ns-105 ;lam-105)

43. Cas-110958-19-5

44. (5r)-5-(piperidine-1-carbonyl) Pyrrolidin-2-one

45. A894820

46. Q5436839

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 196.25 g/mol
Molecular Formula C10H16N2O2
XLogP30
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass196.121177757 g/mol
Monoisotopic Mass196.121177757 g/mol
Topological Polar Surface Area49.4 Ų
Heavy Atom Count14
Formal Charge0
Complexity247
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Fasoracetam Manufacturers

A Fasoracetam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fasoracetam, including repackagers and relabelers. The FDA regulates Fasoracetam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fasoracetam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Fasoracetam Suppliers

A Fasoracetam supplier is an individual or a company that provides Fasoracetam active pharmaceutical ingredient (API) or Fasoracetam finished formulations upon request. The Fasoracetam suppliers may include Fasoracetam API manufacturers, exporters, distributors and traders.

click here to find a list of Fasoracetam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Fasoracetam USDMF

A Fasoracetam DMF (Drug Master File) is a document detailing the whole manufacturing process of Fasoracetam active pharmaceutical ingredient (API) in detail. Different forms of Fasoracetam DMFs exist exist since differing nations have different regulations, such as Fasoracetam USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Fasoracetam DMF submitted to regulatory agencies in the US is known as a USDMF. Fasoracetam USDMF includes data on Fasoracetam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fasoracetam USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Fasoracetam suppliers with USDMF on PharmaCompass.

Fasoracetam NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fasoracetam as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Fasoracetam API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Fasoracetam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Fasoracetam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fasoracetam NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Fasoracetam suppliers with NDC on PharmaCompass.

Fasoracetam GMP

Fasoracetam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Fasoracetam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fasoracetam GMP manufacturer or Fasoracetam GMP API supplier for your needs.

Fasoracetam CoA

A Fasoracetam CoA (Certificate of Analysis) is a formal document that attests to Fasoracetam's compliance with Fasoracetam specifications and serves as a tool for batch-level quality control.

Fasoracetam CoA mostly includes findings from lab analyses of a specific batch. For each Fasoracetam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Fasoracetam may be tested according to a variety of international standards, such as European Pharmacopoeia (Fasoracetam EP), Fasoracetam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fasoracetam USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty